Two cases of chronic hepatitis C with sustained virological response in whom serum HCV RNA reappeared two or twelve years after the end of IFN treatment

Kanzo/Acta Hepatologica Japonica

Volumn 47, Issue 12, 2006, Pages 550-557

  Nakayama, Haruo ^a   Ojima, Toshiaki ^a   Kusano, Masao ^a   Endo, Kazunori ^b   Takahashi, Masaharu ^b   Sugai, Yoshiki ^a  

^a Iwaki Kyoritsu Gen Hosp   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2A INTERFERON; ALPHA2B INTERFERON; ANTIBODY; BETA INTERFERON; C22 ANTIBODY; RIBAVIRIN; UNCLASSIFIED DRUG; VIRUS RNA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; NUCLEOTIDE SEQUENCE; PHYLOGENY; RISK; SCHOOL CHILD; UNINDEXED SEQUENCE; VIRUS REACTIVATION;

EID: 53849138065     PISSN: 04514203     EISSN: None     Source Type: Journal    
DOI: 10.2957/kanzo.47.550     Document Type: Article

References (22)

1. Lau DT, Kleiner DE, Ghany MG, et al. 10-Year follow-up after interferon-alpha therapy for chronic hepatitis C. Hepatology 1998; 28: 1121-1127
2. Poynard T, Marcellin P, Lee SS, et al. Randomized trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT). Lancet 1998; 352 (9138): 1426-1432
3. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with Interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet 2001; 358 (9286): 958-965
4. Pham TN, MacParland SA, Mulrooney PM, et al. Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J Virol 2004; 78: 5867-5874
5. Radkowski M, Gallegos-Orozco JF, Jablonska J, et al. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 2005; 41: 106-114
6. Nakayama H, Sugai Y, Ikeya S, et al. Molecular investigation of interspousal transmission of hepatitis C virus in two Japanese patients who acquired acute hepatitis C after 40 or 42 years of marriage. J Med Virol 2005; 75: 258-266
7. Dickson RC, Everhart JE, Lake JR, et al. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Disease Liver Transplantation Database. Gastroenterology 1997; 113: 1668-1674
8. Lee WM, Polson JE, Carney DS, et al. Reemergence of hepatitis C virus after 8.5 years in a patient with hypogammaglobulinemia: evidence for an occult viral reservoir. J Infect Dis 2005; 192: 1088-1092
9. Marcellin P, Boyer N, Gervais A, et al. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy. Ann Intern Med 1997; 127: 875-881
10. McHutchison JG, Davis G, Esteban-Mur R, et al. Durability of sustained virological response in patients with chronic hepatitis C after treatment with interferon alpha-2B alone or in combination with ribavirin [Abstract]. Hepatology 2001; 34: 244A
11. Veldt BJ, Saracco G, Boyer N, et al. Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy. Gut 2004; 53: 1504-1508
12. Japanese source
13. Japanese source
14. Japanese source
15. Japanese source
16. Japanese source
17. Japanese source
18. Japanese source
19. Japanese source
20. Japanese source
21. Ciacio A, Smedile A, Giordanino C, et al. Long-term follow-up of previous hepatitis C virus positive non-responders to interferon monotherapy successfully retreated with combination therapy Are they really cured? Am J Gastroenterol 2006; 101: 1811-1816
22. Japanese source